Articles Referencing CUR

Neuralstem: Update On Phase I Trial Of Neural Stem Cells In ALS Is Encouraging

5/21/2013, 8:18 am from SeekingAlpha in Investing, Stocks

By Smith On Stocks : Purpose of Report CUR blog Investment Conclusion Before I state my conclusions let me quote the lead investigator on the study, Dr. Eva Feldman. She said... Read >>

Neuralstem: Anticipating More Efficacy Data From ALS Trial And Update On New Clinical Trials

5/7/2013, 2:07 pm from SeekingAlpha in Investing, Stocks

By Smith On Stocks : Investment Opinion and Thesis CUR As will be discussed in this report, the first part of the phase I study in ALS allowed a meaningful evaluation of efficacy in... Read >>

Neuralstem Is Speculative, But Its Work In Stem Cell Therapy Can't Be Ignored

11/6/2012, 12:15 am from SeekingAlpha in Investing, Stocks

By Smith On Stocks : Introduction I think that the potential of stem cell therapy has captured the imagination of most biotechnology investors who see it as a new potential driver for the... Read >>

Welcome to Earnings Season! Here Are The Stocks to Watch

10/10/2011, 9:45 pm from Kapitall in Investing, Investing Ideas, Stocks

(Written by Rebecca Lipman.   List compiled by Eben Esterhuizen, CFA. Data sourced from Yahoo! Finance. ) Welcome to earnings season, a time when investors adjust positions based on... Read >>

9 Biotech Penny Stocks to Buy

8/30/2010, 4:57 pm from Louis Navellier in Investing, Stocks

Penny stock investments in the biotech sector abound right now after the recent market turmoil this summer. Healthcare and biotech penny stocks can be volatile, particularly those drug... Read >>